$BNTC
Benitec Biopharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$8.76
▲+0.11%+$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBenitec Biopharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $8.11 at 08:01 AM on Oct 05, then ran to $9.99 +23% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is BNTC up today? It is at $8.76 (+0.00%), and our scanner flagged it 21 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BNTC spikes, and full due diligence on BNTC — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BNTC 21 times in the last 30 days. Create a free account to track $BNTC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BNTC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BNTC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing8-KRegulation FD DisclosureOct 5, 2026 · 3 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Buchi J Kevin Director | Sold (automatic/other) | -52K 0.1% of company | sold 50% | 52K | n/a | Jun 29, 26 |
Montanova Capital, Llc Director | Bought (open market) | +77K 0.2% of company | added 0.2% | 34.47M | $1.0M at $13.44 | Dec 29, 25 |
Montanova Capital, Llc Director | Bought (open market) | +17K 0.05% of company | added 0.2% | 9.63M | $221K at $13.10 | Dec 26, 25 |
Montanova Capital, Llc Director | Bought (open market) | +50K 0.1% of company | added 0.5% | 9.62M | $643K at $12.85 | Dec 23, 25 |
Montanova Capital, Llc Director | Bought (open market) | +20K 0.06% of company | added <0.1% | 34.16M | $236K at $12.08 | Dec 22, 25 |
Montanova Capital, Llc Director | Bought (open market) | +16K 0.05% of company | added 0.2% | 9.56M | $188K at $11.48 | Dec 19, 25 |
Montanova Capital, Llc Director | Bought (open market) | +10K 0.03% of company | added 0.1% | 9.55M | $115K at $11.24 | Dec 18, 25 |
Montanova Capital, Llc Director | Bought (open market) | +1.48M 4.2% of company | added 15% | 11.36M | $20.0M at $13.50 | Nov 7, 25 |
Montanova Capital, Llc Director | Bought (open market) | +16K 0.05% of company | added <0.1% | 19.75M | $208K at $12.63 | Mar 31, 25 |
Montanova Capital, Llc Director | Bought (open market) | +900K 2.6% of company | added 10% | 9.86M | $11.7M at $13.00 | Mar 26, 25 |
Buchi J Kevin Director | Sold (automatic/other) | -104K 0.3% of company | sold 100% | 284 | n/a | Mar 12, 25 |
Buchi J Kevin Director | Acquired (grant/award) | +104K 0.3% of company | n/a | 104K | n/a | Mar 12, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BNTC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BNTC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BNTC last traded at $8.76, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Benitec Biopharma Inc. Common Stock (BNTC) is next expected to report earnings on Friday, November 13, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BNTC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BNTC 21 times in the last 30 days.
BNTC (Benitec Biopharma Inc. Common Stock) trades on XNAS, with a market cap of about $305M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BNTC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BNTC discussion
Sign in to ask a question or join the discussion.